Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0QB8Q
|
||||
| Former ID |
DIB015071
|
||||
| Drug Name |
EP-2167
|
||||
| Synonyms |
EP-2167; MX-2167; Transferrin modulating apoptosis inducers (cancer); Transferrin modulating apoptosis inducers (cancer), EpiCept;Transferrin modulating apoptosis inducers (cancer), Maxim
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Preclinical | [547623] | ||
| Company |
Maxim Pharmaceuticals Inc
|
||||
| Target and Pathway | |||||
| Target(s) | Transferrin | Target Info | Inducer | [547622] | |
| KEGG Pathway | HIF-1 signaling pathway | ||||
| Mineral absorption | |||||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
| Pathway Interaction Database | EPHB forward signaling | ||||
| HIF-1-alpha transcription factor network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

